In November 2021, a mid-to-late stage study showed that an antiviral medication was nearly 90% effective in preventing hospitalisations and deaths in adults at high risk of severe illness. By December, the Paxlovid was cleared for Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) in America and is now used to treat…